期刊文献+

瑞芬太尼抑制老年患者气管插管反应的最低有效浓度 被引量:4

Minimal effective remifentanil concentration for inhibiting response to tracheal intubation in elderly patients
下载PDF
导出
摘要 目的探讨抑制50%老年患者气管插管过程中血流动力学波动的瑞芬太尼靶控输注(TCI)血浆靶浓度(EC50)。方法选择我院2012年3-6月期间,26例年龄65~78岁ASAⅠ-Ⅱ级拟行2 h以内择期手术患者。所有患者在脑电双频指数(bispectralindex,BIS)引导下丙泊酚联合瑞芬太尼全凭静脉诱导抑制丙泊酚TCI血浆靶浓度3μg/ml,预设第1例患者瑞芬太尼TCI血浆靶浓度4 ng/ml,依据Dixon上下序贯法原则决定下一例患者的瑞芬太尼血浆靶浓度。结果气管插管前、后BIS值无明显差异。采用Dixon序贯法计算得到的瑞芬太尼抑制老年患者气管插管血流动力学反应的EC50为1.93 ng/ml,其95%可信区间(CI)为1.63~2.23 ng/ml。结论在维持丙泊酚TCI 3μg/ml时,1.93 ng/ml瑞芬太尼可抑制50%老年患者接受气管插管时的心血管反应。 Objective To study the effective remifentanil plasma concentration(EC50) for inhibiting hemodynamic response to tracheal intubation in 50% elderly patients when propofol anesthesia was guided by bispectral index(BIS).Methods Twenty-six ASAⅠ-Ⅱelderly patients at the age of 65-78 years admitted to our hospital from March 2012 to June 2012 for surgery within 2 hours after admission were included in this study.The patients received target-controlled infusion of 3 μg/ml propofol.The plasma target concentration of remifentanil was preset at 4.0 ng/ml for the first patient whose target plasma remifentanil concentration was decided according to the Dixon's up-and-down sequential allocation.Results No significant difference was found in BIS value before and after tracheal intubation.The EC50 of remifentanil to inhibit the hemodynamic response to tracheal intubation was 1.93 ng/ml and its95% CI was 1.63-2.23 ng/ml according the Dixon's up-and-down sequential allocation.Conclusion Remifentanil at the concentration of 1.93 ng/ml can effectively inhibit the hemodynamic response to tracheal intubation in 50% elderly patients when the concentration of propofol is maintained at 3 μg/ml.
出处 《解放军医学院学报》 CAS 2013年第5期481-483,488,共4页 Academic Journal of Chinese PLA Medical School
关键词 血浆靶浓度 瑞芬太尼 气管插管 老年人 plasma concentration remifentanil tracheal intubation aged
  • 相关文献

参考文献10

  • 1Katzenstein AL,Fiorelli RF. Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance[J].{H}American Journal of Surgical Pathology,1994,(02):136-147.
  • 2American Thoracic Society,European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS),and the European Respiratory Society(ERS)was adopted by the ATS board of directors,June 2001 and by the ERS Executive Committee,June 2001[J].{H}American Journal of Respiratory and Critical Care Medicine,2002,(02):277-304.
  • 3Park IN,Jegal Y,Kim DS. Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia[J].{H}European Respiratory Journal,2009,(01):68-76.
  • 4Flaherty KR,Martinez FJ. Nonspecific interstitial pneumonia[J].{H}Seminars in respiratory and critical care medicine,2006,(06):652-658.
  • 5Flieder DB,Koss MN. Nonspecific interstitial pneumonia:a provisional category of idiopathic interstitial pneumonia[J].{H}Current Opinion in Pulmonary Medicine,2004,(05):441-446.
  • 6Poletti V,Romagnoli M,Piciucchi S. Current status of idiopathic nonspecific interstitial pneumonia[J].{H}Seminars in respiratory and critical care medicine,2012,(05):440-449.
  • 7Hartman TE,Swensen SJ,Hansell DM. Nonspecific interstitial pneumonia:variable appearance at high-resolution chest CT[J].{H}RADIOLOGY,2000,(03):701-705.
  • 8Akira M,Inoue Y,Arai T. Long-term follow-up high-resolution CT findings in non-specific interstitial pneumonia[J].{H}THORAX,2011,(01):61-65.
  • 9Mink SN,Maycher B. Comparative manifestations and diagnostic accuracy of high-resolution computed tomography in usual interstitial pneumonia and nonspecific interstitial pneumonia[J].{H}Current Opinion in Pulmonary Medicine,2012,(05):530-534.
  • 10Bradley B,Branley HM,Egan JJ. Interstitial lung disease guideline:the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society[J].{H}THORAX,2008,(Suppl 5):v1-v58.

同被引文献31

  • 1Stojanka Gaparovi,Nadan Rustemovi,Milorad Opai,Marina Premuzi,Andelko Korui,Jadranka Bozikov,Tamara Bates.Clinical analysis of propofol deep sedation for 1,104 patients undergoing gastrointestinal endoscopic procedures:A three year prospective study[J].World Journal of Gastroenterology,2006,12(2):327-330. 被引量:42
  • 2周仁龙,王珊娟,杭燕南.瑞芬太尼连续输注在老年患者全麻诱导中的应用[J].上海交通大学学报(医学版),2007,27(4):440-442. 被引量:3
  • 3杨璐,张利萍,卢炜,张弨,张现化,翟所迪,段丽萍.成年与老年全麻患者单次静脉注射瑞芬太尼的药动学[J].中国新药杂志,2007,16(15):1218-1221. 被引量:1
  • 4Kim TY,Kim DK,Yoon TG.Myocardial injury in remifentanilbased anaesthesia for off-pump coronary artery bypass surgery:an equipotent dose of sevoflurane versus propofol[J].Anaesth Intensive Care,2011,39(3):418-425.
  • 5孔素梅.丙泊酚靶控输注复合雷米芬太尼麻醉期间右旋美托咪啶对麻醉深度的影响.中国药物经济学,2013,12(2):202-203.
  • 6Shajar AM,Thompson JP,Hall AP,et al. Effect of a remifentanil bolus dose on the cardiovascular response to emergence fromanaesthesia and tracheal extubation[J]. Br J Anaesth, 1999,83 (4) : 654-656.
  • 7Keira P,Mason,Jerrold,Lerman- Review article:Dexmedeto- midine in children:Current knowledge and future apphca- tions[J]. Anesthesia and Analgesia, 2011,113 (5) : 1129- 1142.
  • 8G6wka FK, Kosicka K, Kara niewicz-ada M. HPLC method for determination of fluorescence derivatives of cortisol, cortisone and their tetrahydro-and allo-tetrahydro-metabo- lites in biological fluids[J]. Journal of chromatography. B, Analytical technologies in the biomedical and life sci- ences, 2010,878(3-4) : 283-289.
  • 9Ehab,Farag, Maged,Argalious,Alaa,Abd-Elsayed,Zeyd, Ebrahim,D John, Doyle. The use of dexmedetomidine in anesthesia and intensive care:A review[J]. Current Phar- maceutical Design, 2012, 18(38) : 6257-6265.
  • 10何洹,张春梅,施冲.靶控输注异丙酚复合瑞芬太尼麻醉时NI与BIS监测镇静深度的比较[J].中华麻醉学杂志,2010(3):282-284. 被引量:12

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部